


Tantigen Bio Email Formats
Biotechnology Research • Philadelphia, Pennsylvania, United States • 1-10 Employees
Key Contact at Tantigen Bio
John Maris
Founder
Company overview
| Headquarters | Philadelphia, Pennsylvania, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 1-10 |
About Tantigen Bio
Tantigen is an early-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to solving the bottlenecks that limit the use of cell therapy in low mutational burden solid tumors enabling personalized, platform agnostic cell therapy for all. Tantigen is focused on the discovery of targets in pediatric cancers that are expressed across a range of adult indications, allowing development of treatments for neglected, rare indications as well as more common solid tumors.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Tantigen Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Tantigen Bio has never raised funding before.
Frequently asked questions
4.8
40,000 users



